News

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

Dr. Tim Pluard talks about an exciting expansion that will make cancer care more accessible to Kansas City’s growing Northland community.

Dr. Matthew Wilkinson, a transplant surgeon at Saint Luke’s talks about the advances in organ donation and the importance of living organ donation.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Dr. Tim Pluard, medical director of Saint Luke’s Koontz Center for Advanced Breast Cancer and of Saint Luke’s Cancer Institute, talks about innovative treatment options for breast cancer and clinical trials offered at Saint Luke’s.

We’re talking about how younger women and men can monitor for breast cancer and recent updates in screening guidelines.

This week during Breast Cancer Awareness Month, we’re talking about metastatic breast cancer and Saint Luke’s Koontz Center—the region’s only center dedicated and designed specifically for these patients.

More than 100,000 people are on the wait list for a life-saving transplant—and more than 85% of those can be helped by a living donor.

Over the years, they have done everything together: graduated high school, tied the knot, bought their first home, and raised a family. For all they have shared, they never dreamed of sharing a cancer diagnosis.

Emery Stone was in total kidney failure. And that’s when everything changed. Not only for Emery, but for the entire Stone family.